7.61 USD
-1.52 (-16.67%)
7.5 USD
-0.11 (-1.45%)
We assign a fundamental rating of 2 out of 10 to MTEX. MTEX was compared to 36 industry peers in the Personal Care Products industry. Both the profitability and financial health of MTEX have multiple concerns. MTEX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- MTEX had negative earnings in the past year.
- In the past year MTEX has reported a negative cash flow from operations.
- In multiple years MTEX reported negative net income over the last 5 years.
- In multiple years MTEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
- With a Return On Assets value of -4.88%, MTEX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
- MTEX has a Return On Equity of -23.83%. This is in the lower half of the industry: MTEX underperforms 63.89% of its industry peers.
- MTEX has a Return On Invested Capital (2.75%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.88% | ||
| ROE | -23.83% | ||
| ROIC | 2.75% |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MTEX's Profit Margin has been stable in the last couple of years.
- MTEX has a Operating Margin (0.54%) which is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of MTEX has declined.
- MTEX's Gross Margin of 76.33% is amongst the best of the industry. MTEX outperforms 83.33% of its industry peers.
- MTEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.54% | ||
| PM (TTM) | N/A | ||
| GM | 76.33% |
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTEX is destroying value.
- Compared to 1 year ago, MTEX has more shares outstanding
- The number of shares outstanding for MTEX has been reduced compared to 5 years ago.
- The debt/assets ratio for MTEX is higher compared to a year ago.
2.2 Solvency
- MTEX has an Altman-Z score of 3.61. This indicates that MTEX is financially healthy and has little risk of bankruptcy at the moment.
- MTEX has a Altman-Z score of 3.61. This is in the better half of the industry: MTEX outperforms 66.67% of its industry peers.
- MTEX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
- MTEX has a Debt to Equity ratio (0.48) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.61 |
ROIC/WACC0.29
WACC9.32%
2.3 Liquidity
- MTEX has a Current Ratio of 1.13. This is a normal value and indicates that MTEX is financially healthy and should not expect problems in meeting its short term obligations.
- MTEX has a worse Current ratio (1.13) than 72.22% of its industry peers.
- MTEX has a Quick Ratio of 1.13. This is a bad value and indicates that MTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.56, MTEX is doing worse than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
- The earnings per share for MTEX have decreased by -5.28% in the last year.
- Measured over the past years, MTEX shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.73% on average per year.
- MTEX shows a decrease in Revenue. In the last year, the revenue decreased by -9.17%.
- The Revenue has been decreasing by -5.66% on average over the past years.
EPS 1Y (TTM)-5.28%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%695.35%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-8.08%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for MTEX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- MTEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTEX is cheaper than 86.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.12 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 8.83%, MTEX is a good candidate for dividend investing.
- MTEX's Dividend Yield is rather good when compared to the industry average which is at 1.92. MTEX pays more dividend than 94.44% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, MTEX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
5.2 History
- MTEX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
7.61
-1.52 (-16.67%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-11 2025-11-11
Earnings (Next)03-24 2026-03-24
Inst Owners19.24%
Inst Owner Change0%
Ins Owners44.9%
Ins Owner Change2.85%
Market Cap14.46M
Revenue(TTM)110.41M
Net Income(TTM)-1.66M
Analysts0
Price TargetN/A
Short Float %1.35%
Short Ratio0.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.13 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.08 | ||
| P/tB | 2.08 | ||
| EV/EBITDA | 6.12 |
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.09
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS58.11
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.88% | ||
| ROE | -23.83% | ||
| ROCE | 4.13% | ||
| ROIC | 2.75% | ||
| ROICexc | 5.44% | ||
| ROICexgc | 5.44% | ||
| OM | 0.54% | ||
| PM (TTM) | N/A | ||
| GM | 76.33% | ||
| FCFM | N/A |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-38.98%
ROICexgc growth 5Y-10.83%
ROICexc growth 3Y-39.31%
ROICexc growth 5Y-11.41%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.88 | ||
| Cap/Depr | 89.97% | ||
| Cap/Sales | 0.97% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 3.61 |
F-Score3
WACC9.32%
ROIC/WACC0.29
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.28%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%695.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-8.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y283.08%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.66%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y29.61%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%
MANNATECH INC / MTEX FAQ
Can you provide the ChartMill fundamental rating for MANNATECH INC?
ChartMill assigns a fundamental rating of 2 / 10 to MTEX.
What is the valuation status for MTEX stock?
ChartMill assigns a valuation rating of 1 / 10 to MANNATECH INC (MTEX). This can be considered as Overvalued.
Can you provide the profitability details for MANNATECH INC?
MANNATECH INC (MTEX) has a profitability rating of 2 / 10.
Is the dividend of MANNATECH INC sustainable?
The dividend rating of MANNATECH INC (MTEX) is 5 / 10 and the dividend payout ratio is 0%.